Brumme CJ - Search Results

1

Older Adults Mount Less Durable Humoral Responses to a Two-dose COVID-19 mRNA Vaccine Regimen, but Strong Initial Responses to a Third Dose.

Mwimanzi F, Lapointe HR, Cheung PK, Sang Y, Yaseen F, Umviligihozo G, Kalikawe R, Datwani S, Omondi FH, Burns L, Young L, Leung V, Agafitei O, Ennis S, Dong W, Basra S, Lim LY, Ng K, Pantophlet R, Brumme CJ, Montaner JSG, Prystajecky N, Lowe CF, DeMarco ML, Holmes DT, Simons J, Niikura M, Romney MG, Brumme ZL, Brockman MA. Mwimanzi F, et al. Among authors: brumme zl, brumme cj. medRxiv [Preprint]. 2022 Feb 21:2022.01.06.22268745. doi: 10.1101/2022.01.06.22268745. medRxiv. 2022. Update in: J Infect Dis. 2022 Sep 21;226(6):983-994. doi: 10.1093/infdis/jiac199 PMID: 35018381 Free PMC article. Updated. Preprint.

2

No inherent association between minor mutations in HIV protease at baseline and selection of the L90M mutation at the time of the first virological failure.

Brumme CJ, Harrigan PR. Brumme CJ, et al. J Infect Dis. 2005 May 15;191(10):1778-9; author reply 1779-80. doi: 10.1086/429672. J Infect Dis. 2005. PMID: 15838807 No abstract available.

3

Whole genome deep sequencing of HIV-1 reveals the impact of early minor variants upon immune recognition during acute infection.

Henn MR, Boutwell CL, Charlebois P, Lennon NJ, Power KA, Macalalad AR, Berlin AM, Malboeuf CM, Ryan EM, Gnerre S, Zody MC, Erlich RL, Green LM, Berical A, Wang Y, Casali M, Streeck H, Bloom AK, Dudek T, Tully D, Newman R, Axten KL, Gladden AD, Battis L, Kemper M, Zeng Q, Shea TP, Gujja S, Zedlack C, Gasser O, Brander C, Hess C, Günthard HF, Brumme ZL, Brumme CJ, Bazner S, Rychert J, Tinsley JP, Mayer KH, Rosenberg E, Pereyra F, Levin JZ, Young SK, Jessen H, Altfeld M, Birren BW, Walker BD, Allen TM. Henn MR, et al. Among authors: brumme zl, brumme cj. PLoS Pathog. 2012;8(3):e1002529. doi: 10.1371/journal.ppat.1002529. Epub 2012 Mar 8. PLoS Pathog. 2012. PMID: 22412369 Free PMC article.

4

Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy.

Harrigan PR, Hogg RS, Dong WW, Yip B, Wynhoven B, Woodward J, Brumme CJ, Brumme ZL, Mo T, Alexander CS, Montaner JS. Harrigan PR, et al. Among authors: brumme zl, brumme cj. J Infect Dis. 2005 Feb 1;191(3):339-47. doi: 10.1086/427192. Epub 2004 Dec 22. J Infect Dis. 2005. PMID: 15633092 Clinical Trial.

5

HIV-1 drug resistance: degree of underestimation by a cross-sectional versus a longitudinal testing approach.

Harrigan PR, Wynhoven B, Brumme ZL, Brumme CJ, Sattha B, Major JC, de la Rosa R, Montaner JS. Harrigan PR, et al. Among authors: brumme zl, brumme cj. J Infect Dis. 2005 Apr 15;191(8):1325-30. doi: 10.1086/428852. Epub 2005 Mar 16. J Infect Dis. 2005. PMID: 15776380

6

Rates of antiretroviral resistance among HIV-infected patients with and without a history of injection drug use.

Wood E, Hogg RS, Yip B, Dong WW, Wynhoven B, Mo T, Brumme CJ, Montaner JS, Harrigan PR. Wood E, et al. Among authors: brumme cj. AIDS. 2005 Jul 22;19(11):1189-95. doi: 10.1097/01.aids.0000176219.48484.f1. AIDS. 2005. PMID: 15990572

7

Molecular and clinical epidemiology of CXCR4-using HIV-1 in a large population of antiretroviral-naive individuals.

Brumme ZL, Goodrich J, Mayer HB, Brumme CJ, Henrick BM, Wynhoven B, Asselin JJ, Cheung PK, Hogg RS, Montaner JS, Harrigan PR. Brumme ZL, et al. Among authors: brumme cj. J Infect Dis. 2005 Aug 1;192(3):466-74. doi: 10.1086/431519. Epub 2005 Jun 23. J Infect Dis. 2005. PMID: 15995960

8

Short communication. Association of the CCR5delta32 mutation with clinical response and >5-year survival following initiation of first triple antiretroviral regimen.

Brumme ZL, Henrick BM, Brumme CJ, Hogg RS, Montaner JS, Harrigan PR. Brumme ZL, et al. Among authors: brumme cj. Antivir Ther. 2005;10(7):849-53. Antivir Ther. 2005. PMID: 16312181 Clinical Trial.

9

HIV VprR77Q mutation does not influence clinical response of individuals initiating highly active antiretroviral therapy.

Chui C, Cheung PK, Brumme CJ, Mo T, Brumme ZL, Montaner JS, Badley AD, Harrigan PR. Chui C, et al. Among authors: brumme zl, brumme cj. AIDS Res Hum Retroviruses. 2006 Jul;22(7):615-8. doi: 10.1089/aid.2006.22.615. AIDS Res Hum Retroviruses. 2006. PMID: 16831085 Free PMC article.

10

Effects of human leukocyte antigen class I genetic parameters on clinical outcomes and survival after initiation of highly active antiretroviral therapy.

Brumme ZL, Brumme CJ, Chui C, Mo T, Wynhoven B, Woods CK, Henrick BM, Hogg RS, Montaner JS, Harrigan PR. Brumme ZL, et al. Among authors: brumme cj. J Infect Dis. 2007 Jun 1;195(11):1694-704. doi: 10.1086/516789. Epub 2007 Apr 24. J Infect Dis. 2007. PMID: 17471440

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

128 results

Search Page

Filters